Memorial Hermann Hospital, Texas Medical Center - Clinical Research Unit (CRU) — Houston, Texas

Memorial Hermann Hospital, Texas Medical Center - Clinical Research Unit (CRU) is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Memorial Hermann Hospital, Texas Medical Center - Clinical Research Unit (CRU) has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease, Vaso-occlusive Crisis.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Hermann Hospital, Texas Medical Center - Clinical Research Unit (CRU)?

Memorial Hermann Hospital, Texas Medical Center - Clinical Research Unit (CRU) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Hermann Hospital, Texas Medical Center - Clinical Research Unit (CRU) conducted?

Memorial Hermann Hospital, Texas Medical Center - Clinical Research Unit (CRU) has 2 clinical trials on record, with 1 currently active. Their work covers Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease, Vaso-occlusive Crisis.

Is Memorial Hermann Hospital, Texas Medical Center - Clinical Research Unit (CRU) accredited by Crixeo Health?

Memorial Hermann Hospital, Texas Medical Center - Clinical Research Unit (CRU) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memorial Hermann Hospital, Texas Medical Center - Clinical Research Unit (CRU)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.